Literature DB >> 11867071

Macrophage infiltration and death in the nerve during the early phases of experimental diabetic neuropathy: a process concomitant with endoneurial induction of IL-1beta and p75NTR.

Giancarlo Conti1, Elio Scarpini, Pierluigi Baron, Simona Livraghi, Marco Tiriticco, Roberto Bianchi, Christian Vedeler, Guglielmo Scarlato.   

Abstract

This study describes the infiltration and death of monocyte/macrophages and concomitant endoneurial expression of the pro-inflammatory cytokine interleukin-1beta (IL-1beta) and neurotrophin receptor p75 (p75NTR) in the sciatic nerve at the early phases of experimental diabetic neuropathy induced in Lewis rats by streptozotocin (STZ) intraperitoneal injection. Immunocytochemistry and single nerve fiber immunostaining showed the presence of macrophages in diabetic nerves by weeks 2 and 3 after STZ administration, and the 15% of these cells were TUNEL positive. IL-1beta was evident in scattered macrophages, and along few isolated nerve fibers until week 5, when it became undetectable, in concomitance with complete endoneurial clearance of macrophages. p75NTR showed an up-regulation in the sciatic nerve of diabetic rats that began by week 3 after STZ administration, reached its peak by week 5, and returned then to a barely detectable level by week 6. These findings seem to indicate that macrophages and IL-1beta may be involved in the pathogenesis of diabetic neuropathy, participating not only to nerve damage but also to the promotion of an attempt of regeneration via p75NTR induction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867071     DOI: 10.1016/s0022-510x(01)00684-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  22 in total

1.  Effect of dipyrone and thalidomide alone and in combination on STZ-induced diabetic neuropathic pain.

Authors:  Neha Chauhan; Rajeev Taliyan; Pyare Lal Sharma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-01-17       Impact factor: 3.000

Review 2.  Polyphenols for diabetes associated neuropathy: Pharmacological targets and clinical perspective.

Authors:  Rozita Naseri; Fatemeh Farzaei; Sajad Fakhri; Fardous F El-Senduny; Miram Altouhamy; Roodabeh Bahramsoltani; Farnaz Ebrahimi; Roja Rahimi; Mohammad Hosein Farzaei
Journal:  Daru       Date:  2019-07-27       Impact factor: 3.117

Review 3.  Schwann cell interactions with axons and microvessels in diabetic neuropathy.

Authors:  Nádia P Gonçalves; Christian B Vægter; Henning Andersen; Leif Østergaard; Nigel A Calcutt; Troels S Jensen
Journal:  Nat Rev Neurol       Date:  2017-01-30       Impact factor: 42.937

4.  Targeting Neuroimmune Interactions in Diabetic Neuropathy with Nanomedicine.

Authors:  Mihály Balogh; Jelena M Janjic; Andrew J Shepherd
Journal:  Antioxid Redox Signal       Date:  2022-01       Impact factor: 8.401

Review 5.  Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain.

Authors:  Paola Sacerdote; Silvia Franchi; Sarah Moretti; Mara Castelli; Patrizia Procacci; Valerio Magnaghi; Alberto E Panerai
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-16       Impact factor: 4.147

Review 6.  Mechanisms of disease: the oxidative stress theory of diabetic neuropathy.

Authors:  Claudia Figueroa-Romero; Mahdieh Sadidi; Eva L Feldman
Journal:  Rev Endocr Metab Disord       Date:  2008-12       Impact factor: 6.514

7.  Eosinophilic myenteric ganglionitis is associated with functional intestinal obstruction.

Authors:  M G Schäppi; V V Smith; P J Milla; K J Lindley
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

Review 8.  Diabetic neuropathy: mechanisms to management.

Authors:  James L Edwards; Andrea M Vincent; Hsinlin T Cheng; Eva L Feldman
Journal:  Pharmacol Ther       Date:  2008-06-13       Impact factor: 12.310

9.  Erythropoietin both protects from and reverses experimental diabetic neuropathy.

Authors:  Roberto Bianchi; Belgin Buyukakilli; Michael Brines; Costanza Savino; Guido Cavaletti; Norberto Oggioni; Giuseppe Lauria; Monica Borgna; Raffaella Lombardi; Burak Cimen; Ulku Comelekoglu; Arzu Kanik; Cengiz Tataroglu; Anthony Cerami; Pietro Ghezzi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-12       Impact factor: 11.205

Review 10.  Therapeutic Potential of Polyphenols in the Management of Diabetic Neuropathy.

Authors:  Md Tanvir Kabir; Nuzhat Tabassum; Md Sahab Uddin; Faissal Aziz; Tapan Behl; Bijo Mathew; Md Habibur Rahman; Raushanara Akter; Abdur Rauf; Lotfi Aleya
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.